Frequently Asked Questions about Eisai Co., Ltd. (ESALF)

Name: Eisai Co., Ltd. (ESALF) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Eisai Co., Ltd. (ESALF) do?

Accepted Answer

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generaliz...

Question 2

Is Eisai Co., Ltd. (ESALF) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of ESALF reveals an Altman Z-Score of 2.95 and a Piotroski F-Score of 7/9. These metrics, combined with its 5-year revenue trend ($789.40B most recent), help investors decide if ESALF fits their risk profile.

Question 3

What is the current P/E ratio for ESALF?

Accepted Answer

As of the latest trading session, Eisai Co., Ltd. (ESALF) has a trailing P/E ratio of 33.16.

Question 4

Who is the CEO of Eisai Co., Ltd.?

Accepted Answer

The current Chief Executive Officer of Eisai Co., Ltd. is Haruo Naito.

Question 5

What was ESALF's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Eisai Co., Ltd. reported annual revenues of $789.40B (2025), $741.75B (2024), $744.40B (2023), $756.23B (2022), $645.94B (2021) respectively.

Question 6

Does ESALF pay a dividend?

Accepted Answer

Eisai Co., Ltd. currently pays a dividend to its shareholders, with a trailing dividend yield of 3.16%.

Question 7

How much debt and cash flow does ESALF have?

Accepted Answer

In its latest reporting period, Eisai Co., Ltd. generated $7.15B in Free Cash Flow against a total debt load of $187.52B.

Question 8

What is the Price-to-Book (P/B) ratio of Eisai Co., Ltd.?

Accepted Answer

The Price-to-Book (P/B) ratio for Eisai Co., Ltd. (ESALF) is currently 1.59.

Question 9

What is the Price-to-Sales (P/S) ratio of ESALF?

Accepted Answer

Based on trailing twelve-month data, Eisai Co., Ltd. (ESALF) trades at a Price-to-Sales (P/S) ratio of 1.75.

Question 10

What is Eisai Co., Ltd.'s Return on Equity (ROE)?

Accepted Answer

Eisai Co., Ltd. (ESALF) has a Return on Equity (ROE) of 5.01%, representing its profitability relative to shareholder equity.

Period	Operating CF	CapEx	Free CF	True FCF
2025-03	30.1B	-23B	7.1B	7.1B
2024-03	56B	-24.8B	31.2B	31.2B
2023-03	-1.8B	-34.6B	-36.3B	-36.3B
2022-03	117.6B	-40.5B	77.1B	77.1B
2021-03	73.9B	-38.1B	35.7B	35.7B